Information Provided By:
Fly News Breaks for January 10, 2020
Jan 10, 2020 | 06:50 EDT
Guggenheim analyst Curry Baker does not believe the consent decree extension or updated language between Live Nation Entertainment and the Department of Justice the will impair the company's business model going forward. The language used by the DOJ claims that Live Nation has a "well-earned reputation for threatening behavior and retaliation," but the facts continue to draw from six episodes out of ~5,000, Baker tells investors in a research note. The analyst does not believe that six incidents over a nine-year period constitute a pattern of behavior. Baker views the DOJ's case as "thin" and keeps a Buy rating on Live Nation shares.
News For LYV From the Last 2 Days
May 19, 2022 | 12:25 EDT
Bullish option flow detected in Live Nation with 4,736 calls trading, 3x expected, and implied vol increasing almost 2 points to 57.69%. May-22 90 calls and Jun-22 110 calls are the most active options, with total volume in those strikes near 3,700 contracts. The Put/Call Ratio is 0.39. Earnings are expected on August 2nd.
May 19, 2022 | 09:55 EDT
Notable gainers among liquid option names this morning include Synopsys (SNPS) $292.33 +19.76, Live Nation (LYV) $90.59 +5.20, Moderna (MRNA) $143.87 +6.16, Expedia (EXPE) $124.71 +4.56, and Freeport McMoRan (FCX) $36.45 +1.11.